Breast Reconstruction Industry Overview

The global breast reconstruction market size was estimated at USD 2.0 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 6.54% from 2024 to 2030.

This growth is being aided by the rising breast cancer cases along with the presence of favorable reimbursement policies. Additionally, a rise in the number of breast reconstruction procedures, as well as technological developments, is anticipated to drive market expansion. As per Medicare, breast reconstruction can be reimbursed provided the patient has undergone breast mastectomy owing to breast cancer. Moreover, as per Services Australia, the external breast prosthesis reimbursement program can reimburse breast prostheses after breast cancer. Such factors are expected to propel industry growth.

Gather more insights about the market drivers, restrains and growth of the Breast Reconstruction Market

Moreover, to meet the increasing demand for breast reconstruction, key players are undertaking various strategic initiatives, such as product launches, awareness campaigns, and geographic expansions. For instance, the American Society of Plastic Surgeons and The Plastic Surgery Foundation organized the Breast Reconstruction Awareness Day program on October 18, 2023. The main purpose of this program was to create awareness about breast reconstruction among women when diagnosed with breast cancer. Similarly, in October 2021, Sientra, Inc. along with Mission Plasticos launched a philanthropic initiative, ‘Reshaping Lives: Full Circle’. This was aimed at providing women living in poverty with breast reconstruction post-mastectomy.

Global Breast Reconstruction Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the breast reconstruction market report based on product, shape, end-use, and region:

Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Implants
    • Silicone Breast Implants
    • Saline Breast Implants
  • Tissue Expander
    • Saline Expander
    • Air Tissue Expander
  • Acellular Dermal Matrix

Shape Outlook (Revenue, USD Million, 2018 - 2030)

  • Round Shape
  • Anatomical Shape

End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals
  • Cosmetology Clinics
  • Ambulatory Surgical Centers

Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Browse through Grand View Research's Medical Devices Industry Research Reports.

Key Companies & Market Share Insights

Key players are adopting various strategies, such as geographic expansions, mergers & acquisitions, partnerships, new product launches, and seeking government approvals, to strengthen their foothold in the industry. For instance, in March 2023, Establishment Labs announced entering into a collaborative agreement with companies in Europe and a secondary partner network in Japan, to launch Mia Femtech, a minimally invasive breast aesthetics solution. Similarly, in October 2023, ExxonMobil merged with Pioneer Natural Resources. Key players are investing heavily in research and development to manufacture technologically advanced products:

  • Mentor Medical Systems B.V. (Johnson & Johnson)
  • Allergan, Inc. (AbbVie)
  • Sientra, Inc.
  • Ideal Implant Incorporated
  • Establishment Labs
  • POLYTECH Health & Aesthetics GmbH
  • RTI Surgical
  • Sebbin
  • Integra LifeSciences
  • GC Aesthetics

Order a free sample PDF of the Breast Reconstruction Market Intelligence Study, published by Grand View Research.